statistiche ricercatore

ANGELI, FABIO

Distribuzione geografica

Continente	#
NA - Nord America	23.021
EU - Europa	11.749
AS - Asia	7.372
SA - Sud America	1.349
Continente sconosciuto - Info sul continente non disponibili	500
AF - Africa	142
OC - Oceania	8
Totale	44.141

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	22.651
IT - Italia	6.728
SG - Singapore	2.907
UA - Ucraina	1.673
CN - Cina	1.420
VN - Vietnam	1.307
BR - Brasile	1.127
HK - Hong Kong	1.105
IE - Irlanda	744
DE - Germania	639
GB - Regno Unito	472
SE - Svezia	404
FR - Francia	401
RU - Federazione Russa	345
CA - Canada	180
BD - Bangladesh	130
FI - Finlandia	116
TR - Turchia	97
IN - India	93
MX - Messico	91
AR - Argentina	88
JP - Giappone	78
ID - Indonesia	46
CO - Colombia	35
ZA - Sudafrica	35
EC - Ecuador	34
PK - Pakistan	32
ES - Italia	31
NG - Nigeria	31
PL - Polonia	31
AT - Austria	30
IQ - Iraq	29
NL - Olanda	29
TT - Trinidad e Tobago	20
JM - Giamaica	17
KE - Kenya	17
MA - Marocco	17
SA - Arabia Saudita	17
UZ - Uzbekistan	17
VE - Venezuela	17
MY - Malesia	16
PY - Paraguay	16
HN - Honduras	13
LT - Lituania	13
CR - Costa Rica	12
PH - Filippine	12
BE - Belgio	11
CZ - Repubblica Ceca	11
CH - Svizzera	10
CL - Cile	10
PE - Perù	9
TN - Tunisia	9
EG - Egitto	8
GT - Guatemala	8
HU - Ungheria	8
UY - Uruguay	8
DO - Repubblica Dominicana	7
DZ - Algeria	7
MD - Moldavia	7
RO - Romania	7
AE - Emirati Arabi Uniti	6
AL - Albania	6
AU - Australia	6
EE - Estonia	6
IL - Israele	6
NI - Nicaragua	6
BY - Bielorussia	5
NP - Nepal	5
PR - Porto Rico	5
BB - Barbados	4
BO - Bolivia	4
DK - Danimarca	4
ET - Etiopia	4
GR - Grecia	4
KR - Corea	4
KZ - Kazakistan	4
LB - Libano	4
OM - Oman	4
AM - Armenia	3
BG - Bulgaria	3
EU - Europa	3
JO - Giordania	3
KH - Cambogia	3
MM - Myanmar	3
TW - Taiwan	3
AZ - Azerbaigian	2
BH - Bahrain	2
CG - Congo	2
GE - Georgia	2
HR - Croazia	2
HT - Haiti	2
QA - Qatar	2
RS - Serbia	2
SN - Senegal	2
SV - El Salvador	2
SX - ???statistics.table.value.countryCode.SX???	2
TH - Thailandia	2
AO - Angola	1
BJ - Benin	1
BN - Brunei Darussalam	1
Totale	43.618

Salva come PNG Salva come JPEG

Città	#
Milan	4.714
Ashburn	2.998
Fairfield	2.726
San Jose	2.068
Singapore	1.455
Woodbridge	1.283
Seattle	1.097
Hong Kong	1.096
Wilmington	1.038
Houston	1.032
Council Bluffs	965
Cambridge	930
Jacksonville	883
Dublin	730
Princeton	647
Rome	488
Dallas	476
The Dalles	454
Boardman	442
Ann Arbor	398
Chandler	390
Beijing	346
Lauterbourg	344
Dong Ket	327
Ho Chi Minh City	255
Nyköping	231
San Diego	220
Washington	212
Chicago	207
Los Angeles	198
New York	197
Santa Clara	177
London	156
Hanoi	153
Ogden	135
São Paulo	125
Helsinki	102
Phoenix	74
Tokyo	74
Naples	59
Kocaeli	53
Salt Lake City	53
Mexico City	51
Buffalo	50
Toronto	50
Orem	49
Atlanta	48
Como	48
Guangzhou	46
Shanghai	45
Brooklyn	40
Rio de Janeiro	37
San Francisco	37
Munich	36
Catania	35
Montreal	34
Chennai	31
Tampa	30
Haiphong	29
Hangzhou	29
Belo Horizonte	28
Frankfurt am Main	28
Nuremberg	28
Abuja	27
Des Moines	27
Denver	26
Warsaw	25
Da Nang	24
Boston	23
Brasília	23
Johannesburg	23
Norwalk	23
Stockholm	23
Prescot	22
Elk Grove Village	21
Las Vegas	21
Miami	21
Porto Alegre	21
Kilburn	18
Vienna	18
Zhengzhou	18
Biên Hòa	17
North Bergen	17
Treviglio	17
Amsterdam	16
Hefei	16
Hải Dương	16
Kunming	16
Manchester	16
Redmond	16
Turin	16
Bologna	15
Florence	15
Lancaster	15
Philadelphia	15
Tashkent	15
Charlotte	14
Cleveland	14
Newark	14
Shenzhen	14
Totale	31.515

Salva come PNG Salva come JPEG

Nome	#
Intensive Blood Pressure Lowering and Regression of Left Ventricular Hypertrophy	283
Response to Is Vascular Morning Blood Pressure Surge in the Elderly Resistant to Antihypertensives and More Risky?	226
How can we use the results of ambulatory blood pressure monitoring in clinical practice?	211
Fibrillazione atriale e morte cardiaca improvvisa: Un mistero da risolvere?	211
Optimal Therapy in Hypertensive Subjects with Diabetes Mellitus	208
Circadian rhythm of pulse pressure in hypertension: Prognostic implications	203
Association between periodontal disease and left ventricle mass in essential hypertension	199
The revolution of the anti-diabetic drugs in cardiology	193
Simplifying the ECG Diagnosis of Left Ventricular Hypertrophy	179
Exploring the optimal combination therapy in hypertensive patients with diabetes mellitus	174
Hypertension and Arrhythmias: A Clinical Overview of the Pathophysiology-Driven Management of Cardiac Arrhythmias in Hypertensive Patients	174
Ablation of atrial tachycardia in the setting of prior mitral valve surgery	172
Microcirculation and left-ventricular hypertrophy	167
Good news for beta-blockers in perioperative medicine	166
Adverse prognostic significance of new diabetes in treated hypertensive subjects	164
A Risk Score for Predicting 1-Year Mortality in Patients >= 75 Years of Age Presenting With Non-ST-Elevation Acute Coronary Syndrome	164
Above Which Blood Pressure Level Does the Risk of Atrial Fibrillation Increase?	163
Long-Term Survival in Patients with Post-Operative Atrial Fibrillation after Cardiac Surgery: Analysis from a Prospective Cohort Study	162
Amlodipine and celecoxib for treatment of hypertension and osteoarthritis pain	160
The optimal blood pressure target for patients with coronary artery disease	159
Long-term outcome in patients with non-valvular atrial fibrillation on dabigatran: a prospective cohort study	157
Therapy of Type 2 diabetes: more gliflozines and less metformin?	156
DAY-NIGHT RELATED EVENTS: NIGHTTIME BLOOD PRESSURE FALL AND MORNING BLOOD PRESSURE RISE	156
Safety and efficacy of aliskiren in the treatment of hypertension: a systematic overview	155
Aggressive blood pressure reduction in patients at high vascular risk: Is it dangerous?	153
Additive value of standard ECG for the risk prediction of hypertensive disorders during pregnancy	152
Systolic and Diastolic Blood Pressure Changes in Relation With Myocardial Infarction and Stroke in Patients With Coronary Artery Disease	151
Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and protection from stroke	149
Sudden Cardiac Death in Hypertensive Patients	149
Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation-the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) study	149
Electrocardiographic features of patients with COVID-19 pneumonia	149
How important is to reduce sodium and increase potassium in patients with hypertension?	146
Atrial fibrillation in hypertension - Predictors and outcome	145
PK/PD evaluation of fimasartan for the treatment of hypertension Current evidences and future perspectives	145
Computer analysis of patients using echocardiography with pharmacologic stress test	145
Blood pressure increase after Pfizer/BioNTech SARS-CoV-2 vaccine	145
Angiotensin-converting enzyme inhibitors	144
PROGNOSTIC VALUE OF URIC ACID IN RELATION TO DIFFERENT AMBULATORY BLOOD PRESSURE COMPONENTS IN THE ABP-INTERNATIONAL STUDY	144
Detrimental Effects of Hyperglycemia in Acute Coronary Syndromes: from Pathophysiological Mechanisms to Therapeutic Strategies	143
Interpretation of Ambulatory Blood Pressure Profile for Risk Stratification Keep It Simple	143
Modernization and hypertension: is the link changing?	143
The pivotal link between ACE2 deficiency and SARS-CoV-2 infection	143
ABPM in the prognostic evaluation og hypertension patients	142
Regression of left ventricular hypertrophy and prevention of stroke in hypertensive subjects	142
Ambulatory blood pressure for cardiovascular risk stratification	142
Ambulatory blood pressure monitoring and prognosis in the management of essential hypertension	142
Neutrophil Count for the Identification of Postmenopausal Hypertensive Women at Increased Cardiovascular Risk	142
Role of ambulatory blood pressure monitoring in prehypertension	141
Cardiac biomarkers and left ventricular hypertrophy in relation to outcomes in patients with atrial fibrillation: Experiences from the RE-LY trial	141
Treatment strategies for osteoarthritis patients with pain and hypertension	141
Telmisartan for the reduction of cardiovascular morbidity and mortality	140
What to Do When Blood Pressure Is Between 130/80 and 139/89 mm Hg?	140
Hypertension and the J-curve phenomenon: implications for tight blood pressure control	140
Short- and long-term incidence of stroke in white-coat hypertension	139
Neutrophil Count and Ambulatory Pulse Pressure as Predictors of Cardiovascular Adverse Events in Postmenopausal Women with Hypertension	139
A new QRS score for prediction of successful fibrinolysis in patients with ST-Elevation Myocardial Infarction (STEMI)	139
Reperfusion strategies and myocardial viability: prognostic implications of a new ECG index	139
The emerging role of high-density lipoprotein cholesterol in hypertension trials	138
Aggressive Blood Pressure Lowering Is Dangerous: The J-Curve Con Side of the Argument	138
Left ventricular hypertrophy and stroke in hypertension	138
Aliskiren versus ramipril in hypertension	137
Adverse prognostic significance of new diabetes in treated hypertensive subjects	137
Asymptomatic left ventricular systolic dysfunction in essential hypertension - Prevalence, determinants, and prognostic value	137
Hyperglycemia in acute coronary syndromes: From mechanisms to prognostic implications	137
Pharmacokinetic evaluation and clinical utility of azilsartan medoxomil for the treatment of hypertension	136
Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis	136
Impact of blood pressure variability on cardiac and cerebrovascular complications in hypertension	136
Safety and efficacy of non-vitamin K oral anticoagulants in non-valvular atrial fibrillation: a Bayesian meta-analysis approach	136
Cardiac Benefits of an Intensive Blood Pressure Control in Diabetes Mellitus	135
Safety and efficacy of aliskiren in the treatment of hypertension and associated clinical conditions	135
Early Invasive Versus Selectively Invasive Strategy in Patients With Non-ST- Segment Elevation Acute Coronary Syndrome: Impact of Age	135
Left Ventricular Hypertrophy and Coronary Artery Calcifications: A Dangerous Duet?	135
Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials	135
Atrial activation analysis by surface P wave and multipolar esophageal recording after cardioversion of persistent atrial fibrillation	135
ABPM in the prognostic evaluation of hypertensive patients	134
Echocardiographic left ventricular hypertrophy in hypertension: marker for future events or mediator of events?	134
Pulse pressure affects the relationship between flow-mediated dilatation and cardiovascular risk	134
White-coat hypertension in adults	134
At the beginning of stiffening - Endothelial dysfunction meets "pulsology"	134
Very early initiation of statin therapy and mortality in patients with acute coronary syndrome	134
Blood Pressure Increase following COVID-19 Vaccination: A Systematic Overview and Meta-Analysis	134
Does Malaria Cause Hypertension?	133
Risk of cardiovascular disease in relation to achieved office and ambulatory blood pressure control in treated hypertensive subjects	133
Is Hydrochlorothiazide More Effective on LVH in Nonresponders to Losartan Than in Those to Atenolol?	133
"From Apennines to Andes:" Does Body Mass Index Affect the Relationship Between Age and Blood Pressure?	133
COVID-19: ACE2centric infective disease?	133
Natural history of hypertension subtypes	132
Meta-analysis of effectiveness or lack thereof of angiotensin-converting enzyme inhibitors for prevention of heart failure in patients with systemic hypertension	132
Response to Role of Yin and Yang in Diurnal Blood Pressure Variation for Cardiovascular Disease	132
The clinical significance of white-coat and masked hypertension	132
Prognostic value of serial Electrocardiographic voltage and repolarization changes in essential hypertension: The HEART survey study	132
African Ancestry and Uncontrolled Hypertension: Current Knowledge and Future Perspectives	131
"The Lower the BP the Better" Paradigm in the Elderly Vanished by VALISH?	130
European and US guidelines for arterial hypertension: similarities and differences	130
Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73 913 patients	130
Day-to-day variability of electrocardiographic diagnosis of left ventricular hypertrophy in hypertensive patients. Influence of electrode placement	130
Angiotensin-converting enzyme inhibitors	129
Does the reduction in systolic blood pressure alone explain the regression of left ventricular hypertrophy?	129
Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis	129
Atrial Fibrillation and Mortality in Patients with Acute Myocardial Infarction: A Systematic Overview and Meta-analysis	129
Totale	14.855

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	219.449
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	219.449

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	1.993	0	0	0	87	82	120	182	219	193	442	304	364
2022/2023	1.998	338	75	81	143	90	508	15	228	242	168	56	54
2023/2024	7.937	1.109	1.235	1.190	1.475	1.744	767	45	61	198	39	11	63
2024/2025	4.485	15	41	924	82	79	264	181	167	655	270	402	1.405
2025/2026	10.557	678	587	683	1.732	512	435	2.123	809	1.452	692	526	328
2026/2027	4.039	390	615	1.509	1.525	0	0	0	0	0	0	0	0
Totale													44.141